Gritstone Oncology, Inc. Intellectual Property Contracts & Agreements

5 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No.1 to Nonexclusive License and Development Agreement between the Company and Genevant Sciences GmbH, dated as of January 29, 2021
License Agreements
Gritstone Oncology, Inc.
Biotechnology
2023
Nonexclusive License and Development Agreement between the Company and Genevant Sciences GmbH, dated as of January 15, 2021
License Agreements
Gritstone Oncology, Inc.
Biotechnology
NY
2023
Fourth Amendment to the License Agreement between Gritstone bio, Inc. and MIL 21E, LLC, effective as of June 30, 2022
License Agreements
Gritstone Oncology, Inc.
Biotechnology
2022
Amendment Number One to License Agreement, dated as of July 20, 2018, by and among Gritstone Oncology, Inc., Arbutus Biopharma Corporation and its subsidiary Protiva...
License Agreements
Gritstone Oncology, Inc.
Biotechnology
2018
License Agreement, dated as of October 16, 2017, by and among Gritstone Oncology, Inc., Arbutus Biopharma Corporation and its subsidiary Protiva Biotherapeutics Inc
License Agreements
Gritstone Oncology, Inc.
Biotechnology
CA
2018